tiprankstipranks
Trending News
More News >
Clariant AG (CH:CLN)
:CLN
Advertisement

Clariant AG (CLN) AI Stock Analysis

Compare
10 Followers

Top Page

CH:CLN

Clariant AG

(CLN)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 4o)
Rating:62Neutral
Price Target:
CHF7.50
▲(8.07% Upside)
Clariant AG's overall stock score is driven by a mixed financial performance, with stable profitability but challenges in revenue growth and cash flow. Technical analysis indicates bearish momentum, while valuation metrics suggest potential overvaluation despite a strong dividend yield. The earnings call provided positive insights into margin improvements but highlighted sales growth challenges.
Positive Factors
Margin Improvement
The improvement in EBITDA margin indicates effective cost management and operational efficiency, which can enhance long-term profitability and competitive positioning.
Savings Program
The ongoing savings program reflects Clariant's commitment to cost efficiency, potentially leading to sustained profitability and financial health over the long term.
Care Chemicals Margin Uplift
The margin uplift in Care Chemicals suggests robust pricing power and product mix optimization, supporting Clariant's ability to maintain strong margins in key segments.
Negative Factors
Sales Decline
The decline in sales indicates potential challenges in market demand and competitive pressures, which could impact revenue growth and market share in the medium term.
Catalysts Segment Weakness
Weakness in the Catalysts segment, especially in China, suggests vulnerability to market fluctuations and could hinder overall growth prospects if not addressed.
Challenges in U.S. Renewable Fuels
Regulatory uncertainties and demand weakness in renewable fuels could pose risks to Clariant's growth in the Americas, affecting its strategic positioning in sustainable markets.

Clariant AG (CLN) vs. iShares MSCI Switzerland ETF (EWL)

Clariant AG Business Overview & Revenue Model

Company DescriptionClariant AG is a global specialty chemicals company headquartered in Switzerland, focusing on providing innovative solutions in various sectors including Personal Care, Home Care, Industrial & Consumer Care, Agro Solutions, and Plastics & Coatings. The company develops a wide range of products and services, including additives, pigments, and specialty chemicals that enhance the performance and sustainability of its customers' products across multiple industries.
How the Company Makes MoneyClariant AG generates revenue through the sale of specialty chemicals and products tailored to specific industry needs. The company operates through several key segments, each contributing to its overall revenue. The largest revenue streams come from the Personal Care and Home Care segments, which provide ingredients and formulations to the cosmetics and cleaning industries. Additionally, Clariant benefits from its Agro Solutions segment, which delivers crop protection products and solutions. The company's revenue model is supported by strategic partnerships with various industries, enabling it to innovate and adapt to market demands. Clariant also invests in research and development to create sustainable and high-performance products, which further enhances its competitive edge and profitability.

Clariant AG Earnings Call Summary

Earnings Call Date:Oct 30, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 26, 2026
Earnings Call Sentiment Neutral
Clariant demonstrated strong performance improvement in terms of EBITDA margin and cost management, with significant savings achieved. However, these achievements were tempered by challenges in sales growth, particularly in the Catalysts segment and due to currency effects. The company remains optimistic about maintaining profitability margins despite a challenging market environment.
Q3-2025 Updates
Positive Updates
EBITDA Margin Improvement
Clariant achieved a significant margin improvement of 230 basis points to 17.9%, driven by performance improvement programs and effective price and cost management. EBITDA before exceptional items increased by 5% in absolute terms to CHF 162 million.
Savings Program Progress
Clariant achieved savings of CHF 19 million in Q3, bringing the total savings to CHF 31 million in the first 9 months of 2025. The program is on track to deliver CHF 80 million by 2027.
Care Chemicals Margin Uplift
Care Chemicals recorded a strong margin uplift to 18.9%, representing a 150 basis points improvement, driven by positive mix, pricing discipline, and contributions from the performance improvement programs.
Adsorbents and Additives Growth
Sales in Adsorbents and Additives increased by 1% in local currency, with profitability driven by pricing, mix effects, and benefits from performance improvement programs.
Negative Updates
Sales Decline
Clariant experienced a 3% decrease in sales in local currencies and a 9% decrease in Swiss francs, impacted by a 6% negative currency translation effect.
Catalysts Segment Weakness
Sales in the Catalysts segment decreased by 8% in local currency due to lower volumes and weak demand, particularly in China, with a high double-digit percentage rate decline in Propylene and Catalysts.
Challenges in U.S. Renewable Fuels
Adsorbents sales in the Americas decreased at a high single-digit percentage rate, impacted by regulatory uncertainties and temporary weakness in demand for biodiesel and SAF.
Company Guidance
In the recent third-quarter conference call, Clariant provided guidance for the full year 2025, indicating that the company expects local currency sales growth at the lower end of its 1% to 3% range, attributable to weaker industrial production and consumer sentiment. The company reaffirmed its profitability target, projecting an EBITDA margin before exceptional items of 17% to 18%, reflecting confidence in maintaining improved profitability levels. Clariant achieved significant growth in EBITDA before exceptional items in Q3 2025, with an increase of 5% in absolute terms to CHF 162 million, despite a 3% sales decrease in local currencies. The company also reported a margin improvement of 230 basis points to 17.9%, supported by performance improvement programs and effective price and cost management. Clariant's savings program contributed CHF 19 million in Q3, bringing total savings to CHF 31 million for the first nine months of 2025, with an ultimate goal of achieving CHF 80 million by 2027. However, the company anticipates booking CHF 75 million in restructuring charges related to this program in 2025.

Clariant AG Financial Statement Overview

Summary
Clariant AG shows mixed financial performance. Strong operational margins and stable profitability are offset by declining revenue growth and cash flow challenges. The balance sheet remains stable with moderate leverage, but asset growth is limited.
Income Statement
Clariant AG's income statement shows mixed performance. The gross profit margin for 2024 stands at 30.31%, indicating solid cost management. However, the net profit margin is 5.88%, reflecting a slight improvement from previous years. The revenue growth rate from 2023 to 2024 is -5.14%, signaling a decline in revenue. EBIT and EBITDA margins are 10.60% and 16.77%, respectively, showing an improvement in operational profitability compared to last year.
Balance Sheet
The balance sheet analysis reveals a stable financial structure with a debt-to-equity ratio of 0.81, suggesting moderate leverage. The return on equity is 10.45%, indicating decent profitability. The equity ratio stands at 37.28%, reflecting a balanced capital structure. However, the total assets have slightly declined, suggesting potential constraints in asset growth.
Cash Flow
Clariant AG's cash flow statement presents a challenging picture. The free cash flow growth rate is -2.34%, indicating a slight decrease in liquidity. The operating cash flow to net income ratio is 1.71, showing strong cash generation. However, the free cash flow to net income ratio is 0.86, suggesting room for improvement in free cash flow relative to earnings.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue4.06B4.15B4.38B5.20B4.37B3.86B
Gross Profit1.29B1.26B1.20B1.02B1.29B1.17B
EBITDA568.00M696.00M562.00M296.00M679.00M633.00M
Net Income113.00M244.00M134.00M-101.00M344.00M116.00M
Balance Sheet
Total Assets5.82B6.26B5.35B6.19B7.04B6.93B
Cash, Cash Equivalents and Short-Term Investments449.00M471.00M593.00M758.00M476.00M1.05B
Total Debt2.05B1.88B1.35B1.46B1.95B2.02B
Total Liabilities3.74B3.76B3.17B3.67B4.49B4.55B
Stockholders Equity1.91B2.33B2.02B2.34B2.36B2.24B
Cash Flow
Free Cash Flow179.00M209.00M214.00M290.00M3.00M70.00M
Operating Cash Flow374.00M418.00M421.00M502.00M363.00M369.00M
Investing Cash Flow-216.00M-805.00M45.00M140.00M-143.00M1.08B
Financing Cash Flow-198.00M277.00M-356.00M-652.00M-538.00M-1.33B

Clariant AG Technical Analysis

Technical Analysis Sentiment
Negative
Last Price6.94
Price Trends
50DMA
7.53
Negative
100DMA
7.99
Negative
200DMA
8.63
Negative
Market Momentum
MACD
-0.12
Negative
RSI
31.91
Neutral
STOCH
22.79
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:CLN, the sentiment is Negative. The current price of 6.94 is below the 20-day moving average (MA) of 7.15, below the 50-day MA of 7.53, and below the 200-day MA of 8.63, indicating a bearish trend. The MACD of -0.12 indicates Negative momentum. The RSI at 31.91 is Neutral, neither overbought nor oversold. The STOCH value of 22.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CH:CLN.

Clariant AG Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
CHF30.21B27.612.15%5.93%6.00%
67
Neutral
CHF23.99B19.612.41%-1.05%-1.46%
62
Neutral
CHF2.29B20.175.38%5.99%-2.40%38.08%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
$12.45B26.9722.08%3.14%-4.25%-0.03%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CH:CLN
Clariant AG
6.94
-4.74
-40.56%
CH:GIVN
Givaudan SA
3,274.00
-572.93
-14.89%
CH:SIKA
Sika AG
149.50
-87.48
-36.91%
CH:EMSN
EMS-CHEMIE HOLDING AG
532.50
-111.09
-17.26%

Clariant AG Corporate Events

Clariant AG Reports Improved Profitability Amid Sales Decline
Oct 31, 2025

Clariant AG is a Switzerland-based specialty chemical company focusing on sustainability and innovation, operating through its three business units: Care Chemicals, Catalysts, and Adsorbents & Additives.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 05, 2025